WallStreetZenWallStreetZen

NASDAQ: CTMX
Cytomx Therapeutics Inc Stock Ownership - Who owns Cytomx Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Cytomx Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sean A. McCarthyCEO2024-03-26109,768$1.58
$172.88kBuy
Christopher OgdenSVP Finance and Accounting2024-03-192,971$2.09
$6.20kSell
Sean A. McCarthyCEO2024-03-1920,223$2.09
$42.19kSell
Lloyd A. RowlandGeneral Counsel2024-03-195,268$2.09
$10.99kSell
Marcia BelvinSVP Chief Scientific Officer2024-03-1912,795$2.09
$26.69kSell
Jeffrey B. LandauChief Business Officer2024-03-196,562$2.09
$13.69kSell
Sean A. McCarthyCEO2023-12-2013,551$1.38
$18.71kSell
Marcia BelvinSVP Chief Scientific Officer2023-12-204,077$1.38
$5.63kSell
Jeffrey B. LandauChief Business Officer2023-12-204,077$1.38
$5.63kSell
Christopher OgdenSVP Finance and Accounting2023-12-201,990$1.38
$2.75kSell

1 of 2

CTMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTMX insiders and whales buy or sell their stock.

CTMX Shareholders

What type of owners hold Cytomx Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc9.74%6,595,801$10.55MInstitution
Tang Capital Management LLC9.67%6,550,000$10.48MInstitution
Kevin P. Starr7.68%5,201,767$8.32MInsider
Vanguard Group Inc7.24%4,902,943$7.84MInstitution
Timothy M. 1. Shannon6.74%4,563,247$7.30MInsider
Robert I. Tepper6.42%4,349,864$6.96MInsider
Acadian Asset Management LLC3.91%2,646,190$4.23MInstitution
Canaan Ix LP3.68%2,494,381$3.99MInsider
Renaissance Technologies LLC1.96%1,325,700$2.12MInstitution
Blackrock Inc1.68%1,136,135$1.82MInstitution

1 of 3

CTMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTMX48.20%30.89%Net BuyingNet Buying
LIFE60.86%22.55%Net BuyingNet Selling
CTXR16.86%7.74%
GLYC35.53%64.47%Net BuyingNet Buying
OTLK13.26%86.74%Net BuyingNet Buying
View Top Biotech Stocks

Cytomx Therapeutics Stock Ownership FAQ

Who owns Cytomx Therapeutics?

Cytomx Therapeutics (NASDAQ: CTMX) is owned by 48.20% institutional shareholders, 30.89% Cytomx Therapeutics insiders, and 20.91% retail investors. Kevin P. Starr is the largest individual Cytomx Therapeutics shareholder, owning 5.20M shares representing 7.68% of the company. Kevin P. Starr's Cytomx Therapeutics shares are currently valued at $8.27M.

If you're new to stock investing, here's how to buy Cytomx Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.